A detailed history of Acadian Asset Management LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Acadian Asset Management LLC holds 2,099 shares of TECH stock, worth $153,688. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,099
Previous 1,676 25.24%
Holding current value
$153,688
Previous $120,000 39.17%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$70.96 - $82.35 $30,016 - $34,834
423 Added 25.24%
2,099 $167,000
Q2 2024

Aug 06, 2024

BUY
$62.12 - $84.15 $104,113 - $141,035
1,676 New
1,676 $120,000
Q3 2022

Nov 14, 2022

SELL
$282.54 - $391.85 $379,168 - $525,862
-1,342 Reduced 35.1%
2,481 $701,000
Q3 2022

Nov 14, 2022

SELL
$282.54 - $391.85 $379,168 - $525,862
-1,342 Reduced 35.1%
2,481 $701,000
Q2 2022

Aug 09, 2022

BUY
$322.67 - $449.65 $1.23 Million - $1.72 Million
3,823 New
3,823 $1.33 Million
Q1 2022

May 12, 2022

SELL
$353.85 - $487.79 $320,941 - $442,425
-907 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$387.35 - $450.26 $82,118 - $95,455
-212 Reduced 18.95%
907 $408,000
Q1 2021

May 11, 2021

BUY
$314.62 - $411.0 $40,585 - $53,019
129 Added 13.03%
1,119 $427,000
Q3 2020

Nov 09, 2020

BUY
$232.22 - $282.96 $229,897 - $280,130
990 New
990 $245,000
Q2 2020

Aug 12, 2020

SELL
$185.43 - $279.56 $94,198 - $142,016
-508 Closed
0 $0
Q1 2020

May 11, 2020

BUY
$161.17 - $221.51 $81,874 - $112,527
508 New
508 $96,000
Q3 2019

Nov 07, 2019

SELL
$183.56 - $216.72 $6,424 - $7,585
-35 Closed
0 $0
Q2 2019

Aug 08, 2019

BUY
$188.72 - $215.43 $6,605 - $7,540
35 New
35 $7,000
Q3 2018

Oct 30, 2018

SELL
$147.44 - $204.11 $1,032 - $1,428
-7 Closed
0 $0
Q2 2018

Jul 24, 2018

BUY
$144.9 - $165.58 $1,014 - $1,159
7 New
7 $1,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.87B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.